Table 1. Published studies for different use-cases of sero-epidemiology by pathogen and source of infection.
Primary source of infection | Pathogen for consideration in an integrated platform | Incidence rate estimates from cross-sectional data | Cumulative infection rate estimates (lasting/saturating Abs) | Vaccine vs. natural infection potentially discernible | Cross-sectional correlates of protection | Used for confirming elimination | Multi-pathogen surveillance via multiplex bead assays |
---|---|---|---|---|---|---|---|
Blood and/or other bodily fluids | Chlamydia trachomatis | [23] | [24] | [15,17,25,26] | |||
Ebola virus | [15] | ||||||
Hepatitis B virus | [2] | [27] | |||||
Hepatitis C virus | |||||||
HIV | [28–32] | [15] | |||||
Neisseria meningitidis | |||||||
Food, water, and/or soil | Campylobacter jejuni | [33,34] | [35,36] | [35] | |||
Clostridium tetani | [37] | [2] | [38] | [19] | [6,15,17] | ||
Cryptosporidium parvum | [35] | [15,17,35] | |||||
Enterotoxigenic Escherichia coli | [35] | [35] | |||||
Giardia intestinalis | [35] | [15,17,35] | |||||
Hepatitis A virus | [39] | [27] | |||||
Hepatitis E virus | [40] | [41] | |||||
Lassa virus | [15] | ||||||
Norovirus | [35] | [35] | |||||
Poliovirus | [42] | ||||||
Salmonella enterica serotype enteriditis | [43,44] | [35] | [15,35] | ||||
Salmonella enterica serotype typhimurium | [45] | [15] | |||||
Schistosoma haematobium | [46] | ||||||
Schistosoma mansoni | [47] | [48] | [15,20,46] | ||||
Shigella | |||||||
Strongyloides stercoralis | [49] | [15,17,20] | |||||
Taenia solium | [15,17] | ||||||
Toxoplasma gondii | [50] | [51] | [17] | ||||
Vibrio cholerae | [9,52] | [53,54] | [35] | ||||
Respiratory droplets and/or aerosols | Bordetella pertussis | [55] | [27,56] | [15] | |||
Corynebacterium diphtheriae | [57] | [57] | [15,17] | ||||
Haemophilus influenzae B | [27,38] | ||||||
Measles | [2] | [2] | [15,17] | ||||
Mumps | [58] | [58] | [15,17] | ||||
Respiratory syncytial virus | |||||||
Rhinoviruses | |||||||
Rubella | [2] | [2] | [15,17] | ||||
SARS-CoV-2 | [59] | [60,61] | |||||
Arthropod vectors | Chikungunya virus | [62] | [7,8] | [63] | [15,64] | ||
Crimean-Congo hemorrhagic fever virus | [15] | ||||||
Dengue virus | [65,66] | [67] | [15] | ||||
Mayaro virus | [68] | [67] | [68] | ||||
Onchocerca volvulus | [48] | [15] | |||||
Plasmodium falciparum and Plasmodium vivax | [5,69,70] | [15,17,20] | |||||
Vector saliva antigens | |||||||
Wuchereria bancrofti and Brugia malayi | [48] | [15,17,20] | |||||
Yellow fever virus | |||||||
Zika virus | [64,67] |